Shares of the energy drink maker Monster Beverage were in need of a jolt Thursday.
Monster shares (MNST) fell 7% after the company reported a drop in first quarter earnings and weaker-than-expected sales growth.
The company said late Wednesday that earnings were hurt by costs related to the termination of certain distribution agreements. It also cited expenses tied to various lawsuits against Monster.
The city attorney in San Francisco, Dennis Herrera, filed a lawsuit earlier this week claiming that Monster markets highly caffeinated drinks to children, despite evidence that energy drinks can cause significant health problems for young people, including death.
Monster had previously filed a complaint against Herrera's office in federal court.
The Food and Drug Administration said last year that it was investigating reports from consumers that linked Monster energy drinks to five deaths. The reports were disclosed as part of a lawsuit filed by the parents of a Maryland girl who died in December from heart problems after drinking Monster Energy on two consecutive days.
Monster has refuted the claims, saying its drinks are safe and contain less caffeine than conventional coffeehouse drinks.
In a call Wednesday with analysts, Monster CEO Rodney Sacks called Herrera's lawsuit a "misguided crusade against the company."
Meanwhile, investors were also disappointed by Monster's sales growth, which has been in the double-digits over the past few years.
Gross sales rose 7.3% in the first quarter, down from 16.6% in the previous quarter.
Sacks said the overall market for energy drinks has been soft, in part due to the negative publicity around their safety and marketing practices. He said sales continued to weaken in April.
Analysts at Gabelli & Company lowered their rating on Monster stock to hold, pointing to slowing U.S. sales, weak overseas growth and the "constant negative media attention brought about by the recent lawsuits."
Meanwhile, shares of another company in the caffeine business were on a tear.
Other traders noted that there are just too many risks with the stock right now and it's time to bail.
Investors continued to punish Monster Beverage on Tuesday, following reports of the company's energy drink being cited in five deaths.
Shares of Monster Beverage (MNST) fell nearly 12% Tuesday, after closing down 14% in the prior day's session.
The Food and Drug Administration confirmed Monday that it had received five reports claiming that consuming Monster Beverage products resulted in death. The FDA stressed that it has not found any link between MOREBen Rooney - Oct 23, 2012 11:37 AM ET
Shares of Monster Beverage plunged Monday after the company's energy drinks were cited in five deaths reported to the Food and Drug Administration.
Corona, Calif.-based Monster Beverage's (MNST) stock ended the day down 14% on the Nasdaq.
The FDA has received "adverse incident reports" of five deaths involving Monster energy drinks, although the administration has not established a direct link in any case, according to FDA spokeswoman Shelly Burgess.
"We're still looking MOREBen Rooney - Oct 22, 2012 4:00 PM ET
|'Black Panther' brings in a record-breaking box office weekend|
|Sunny days for the economy can't last forever|
|Why sponsors are breaking up with the Olympics|
|Painkiller that once cost $138 is now $2,979|
|Adam Rippon hired by NBC for Olympics coverage|